169 related articles for article (PubMed ID: 24399744)
1. Pharmacokinetic study of benfotiamine and the bioavailability assessment compared to thiamine hydrochloride.
Xie F; Cheng Z; Li S; Liu X; Guo X; Yu P; Gu Z
J Clin Pharmacol; 2014 Jun; 54(6):688-95. PubMed ID: 24399744
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of thiamine derivatives especially of benfotiamine.
Loew D
Int J Clin Pharmacol Ther; 1996 Feb; 34(2):47-50. PubMed ID: 8929745
[TBL] [Abstract][Full Text] [Related]
3. High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfontiamine.
Frank T; Bitsch R; Maiwald J; Stein G
Eur J Clin Pharmacol; 2000 Jun; 56(3):251-7. PubMed ID: 10952481
[TBL] [Abstract][Full Text] [Related]
4. Comparative Pharmacokinetic Analysis of Thiamine and Its Phosphorylated Metabolites Administered as Multivitamin Preparations.
Park WS; Lee J; Hong T; Park G; Youn S; Seo Y; Lee S; Han S
Clin Ther; 2016 Oct; 38(10):2277-2285. PubMed ID: 27707509
[TBL] [Abstract][Full Text] [Related]
5. Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects.
Sheng L; Cao W; Lin P; Chen W; Xu H; Zhong C; Yuan F; Chen H; Li H; Liu C; Yang M; Li X
Drug Des Devel Ther; 2021; 15():1101-1110. PubMed ID: 33727798
[TBL] [Abstract][Full Text] [Related]
6. Liver, plasma and erythrocyte levels of thiamine and its phosphate esters in rats with acute ethanol intoxication: a comparison of thiamine and benfotiamine administration.
Portari GV; Vannucchi H; Jordao AA
Eur J Pharm Sci; 2013 Mar; 48(4-5):799-802. PubMed ID: 23369791
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability assessment of the lipophilic benfotiamine as compared to a water-soluble thiamin derivative.
Bitsch R; Wolf M; Möller J; Heuzeroth L; Grüneklee D
Ann Nutr Metab; 1991; 35(5):292-6. PubMed ID: 1776825
[TBL] [Abstract][Full Text] [Related]
8. Comparative bioavailability of various thiamine derivatives after oral administration.
Greb A; Bitsch R
Int J Clin Pharmacol Ther; 1998 Apr; 36(4):216-21. PubMed ID: 9587048
[TBL] [Abstract][Full Text] [Related]
9. Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrate.
Schreeb KH; Freudenthaler S; Vormfelde SV; Gundert-Remy U; Gleiter CH
Eur J Clin Pharmacol; 1997; 52(4):319-20. PubMed ID: 9248773
[No Abstract] [Full Text] [Related]
10. Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives.
Volvert ML; Seyen S; Piette M; Evrard B; Gangolf M; Plumier JC; Bettendorff L
BMC Pharmacol; 2008 Jun; 8():10. PubMed ID: 18549472
[TBL] [Abstract][Full Text] [Related]
11. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
Pan X; Gong N; Zhao J; Yu Z; Gu F; Chen J; Sun X; Zhao L; Yu M; Xu Z; Dong W; Qin Y; Fei G; Zhong C; Xu TL
Brain; 2010 May; 133(Pt 5):1342-51. PubMed ID: 20385653
[TBL] [Abstract][Full Text] [Related]
12. Comparative autoradiographic investigations on the tissue distribution of benfotiamine versus thiamine in mice.
Hilbig R; Rahmann H
Arzneimittelforschung; 1998 May; 48(5):461-8. PubMed ID: 9638312
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats.
Stracke H; Hammes HP; Werkmann D; Mavrakis K; Bitsch I; Netzel M; Geyer J; Köpcke W; Sauerland C; Bretzel RG; Federlin KF
Exp Clin Endocrinol Diabetes; 2001; 109(6):330-6. PubMed ID: 11571671
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the transdermal delivery of benfotiamine.
Zhu Z; Varadi G; Carter SG
Acta Diabetol; 2016 Apr; 53(2):317-22. PubMed ID: 26141141
[TBL] [Abstract][Full Text] [Related]
15. Thiamine and benfotiamine prevent stress-induced suppression of hippocampal neurogenesis in mice exposed to predation without affecting brain thiamine diphosphate levels.
Vignisse J; Sambon M; Gorlova A; Pavlov D; Caron N; Malgrange B; Shevtsova E; Svistunov A; Anthony DC; Markova N; Bazhenova N; Coumans B; Lakaye B; Wins P; Strekalova T; Bettendorff L
Mol Cell Neurosci; 2017 Jul; 82():126-136. PubMed ID: 28506637
[TBL] [Abstract][Full Text] [Related]
16. Alteration of thiamine pharmacokinetics by end-stage renal disease (ESRD).
Frank T; Bitsch R; Maiwald J; Stein G
Int J Clin Pharmacol Ther; 1999 Sep; 37(9):449-55. PubMed ID: 10507244
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of water- and lipid-soluble thiamin compounds in broiler chickens.
Geyer J; Netzel M; Bitsch I; Frank T; Bitsch R; Krämer K; Hoppe PP
Int J Vitam Nutr Res; 2000 Dec; 70(6):311-6. PubMed ID: 11214357
[TBL] [Abstract][Full Text] [Related]
18. Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose.
Pomero F; Molinar Min A; La Selva M; Allione A; Molinatti GM; Porta M
Acta Diabetol; 2001; 38(3):135-8. PubMed ID: 11827434
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects.
Smithline HA; Donnino M; Greenblatt DJ
BMC Clin Pharmacol; 2012 Feb; 12():4. PubMed ID: 22305197
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of treatment with thiamine or benfotiamine on liver oxidative damage in rat model of acute ethanol intoxication.
Portari GV; Ovidio PP; Deminice R; Jordão AA
Life Sci; 2016 Oct; 162():21-4. PubMed ID: 27545821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
